People channel feed

Grit­stone bio lays off 40% of staff fol­low­ing Covid vac­cine tri­al de­lay

Last year
R&D

Pfiz­er names a VC leader in year of re­set; For­mer Ax­cel­la CEO moves on af­ter com­pa­ny shut­down

Last year
Peer Review

The End­points Slack in­ter­view: DA Wal­lach on mu­sic and sci­ence par­al­lels, phar­ma's biggest dis­rup­tion, and in­vest­ing in Elon

Last year

Ther­mo Fish­er down­sized by 8,000 work­ers in 2023 amid rev­enue de­cline  

Last year
Outsourcing
Manufacturing

Clade Ther­a­peu­tics cuts staff and ap­pears to shut down Eu­ro­pean sub­sidiary

Last year
R&D

Adap­tive Biotech­nolo­gies trims hand­ful of jobs as strate­gic re­view nears com­ple­tion

Last year

Emer­gent calls on new CEO Joe Pa­pa to lead turn­around fol­low­ing pan­dem­ic stum­bles

Last year
Pharma

Rick Gon­za­lez de­fend­ed Ab­b­Vie's em­pire. The next CEO will have to build a new one be­yond Hu­mi­ra

Last year
Pharma

Ab­b­Vie CEO Richard Gon­za­lez to re­tire Ju­ly 1 with Hu­mi­ra tran­si­tion un­der­way

Last year
Pharma

Sofinno­va’s Ma­ha Katabi on re­cent M&A and IPO suc­cess and how deal flow has ‘nev­er been any bet­ter’

Last year
Financing
Startups

Gri­fols fam­i­ly to step away fur­ther from op­er­a­tions; en­Gene CEO re­signs, cit­ing health rea­sons

Last year
Peer Review

Au­rinia fails to find buy­er, will shed pipeline to fo­cus on Lup­ky­nis

Last year
R&D

Ahead of share­hold­er vote on SQZ as­set sale and liq­ui­da­tion, founder Ar­mon Sharei says he will vote yes

Last year
R&D

Lian­Bio to shut­ter, end­ing Shang­hai-based start­up’s transat­lantic am­bi­tions

Last year
Startups
China

The End­points Slack in­ter­view: Zavain Dar on start­ing a new VC, trust­ing the process with the 76ers, and Ap­ple's VR fu­ture

Last year
Financing

Up­dat­ed: Ex­sci­en­tia CEO brought down by al­le­ga­tions of in­ap­pro­pri­ate em­ploy­ee re­la­tion­ships, in blow to AI pi­o­neer

Last year

Take­da se­lects for­mer CRISPR Ther­a­peu­tics CMO to lead on­col­o­gy unit; Emile Nuwaysir out at En­so­ma

Last year
Peer Review

Syn­log­ic reach­es end of the road for syn­thet­ic bi­ol­o­gy quest af­ter piv­otal da­ta dis­ap­point

Last year
R&D

Ogilvy Health taps long­time WPP ex­ec Re­na­ta Ma­ia as chief cre­ative of­fi­cer

Last year
Pharma
Marketing

Ex­clu­sive: Ver­tex founder Joshua Boger joins tiny Boston biotech as chair, ahead of mid-stage read­out for de­men­tia drug

Last year

Rare dis­ease biotech Rally­bio cuts 19 staffers and sheds part­nered pre­clin­i­cal pro­grams

Last year

The End­points Slack in­ter­view: How Beam CEO John Evans thinks about the sci­ence and busi­ness of ge­net­ic edit­ing

Last year

Rick Gon­za­lez lays out plan for in­ter­nal can­di­date to take over as Ab­b­Vie's CEO

Last year
Pharma

Biotech job mar­ket bot­toms out, hint­ing at po­ten­tial come­back, ac­cord­ing to Jef­feries

Last year
First page Previous page 13141516171819 Next page Last page
A service from the Financial Times